Through August 15, 2018, the Federal Circuit decided 405 PTAB appeals from IPRs and CBMs. The Federal Circuit affirmed the PTAB on every issue in 304 (75.06%) cases, and reversed or vacated the PTAB on every issue in 49 (12.10%)
The Patent Trial and Appeal Board issued 51 IPR and CBM Final Written Decisions in July, including decisions following remands from the Federal Circuit, cancelling 617 (79%) instituted claims while declining to cancel 143 (18.31%) instituted claims. Patent owners conceded
Through July 15, 2018, the Federal Circuit decided 393 PTAB appeals from IPRs and CBMs. The Federal Circuit affirmed the PTAB on every issue in 296 (75.32%) cases, and reversed or vacated the PTAB on every issue in 46 (11.70%)
The Patent Trial and Appeal Board issued 44 IPR and CBM Final Written Decisions in June, including decisions following remands from the Federal Circuit, cancelling 425 (66.51%) instituted claims while declining to cancel 213 (33.33%) instituted claims. Patent owners conceded
Through June 15, 2018, the Federal Circuit decided 377 PTAB appeals from IPRs and CBMs. The Federal Circuit affirmed the PTAB on every issue in 286 (75.86%) cases, and reversed or vacated the PTAB on every issue in 42 (11.14%)
The Patent Trial and Appeal Board issued 34 IPR and CBM Final Written Decisions in May, including decisions following remands from the Federal Circuit, cancelling 322 (68.51%) instituted claims while declining to cancel 122 (25.96%) instituted claims. Patent owners conceded
Through May 15, 2018, the Federal Circuit decided 364 PTAB appeals from IPRs and CBMs. The Federal Circuit affirmed the PTAB on every issue in 276 (75.82%) cases, and reversed or vacated the PTAB on every issue in 41 (11.26%)
The Patent Trial and Appeal Board issued 41 IPR and CBM Final Written Decisions in April, including decisions following remands from the Federal Circuit, cancelling 323 (62.36%) instituted claims while declining to cancel 195 (37.64%) instituted claims. Patent owners did
Through April 15, 2018, the Federal Circuit decided 346 PTAB appeals from IPRs and CBMs. The Federal Circuit affirmed the PTAB on every issue in 260 (75.14%) cases, and reversed or vacated the PTAB on every issue in 40 (11.56%)
